Edoardo CharbonEdoardo Charbon (SM’00 F’17) received the Elektrotechnik Diploma from ETH Zurich, the M.S. from the University of California at San Diego, and the Ph.D. from the University of California at Berkeley in 1988, 1991, and 1995, respectively, all in electrical engineering and EECS. He has consulted with numerous organizations, including Bosch, X-Fab, Texas Instruments, Maxim, Sony, Agilent, and the Carlyle Group. He was with Cadence Design Systems from 1995 to 2000, where he was the architect of the company's initiative on information hiding for intellectual property protection. In 2000, he joined Canesta Inc., as the Chief Architect, where he led the development of wireless 3-D CMOS image sensors. Since 2002 he has been a member of the faculty of EPFL, where is a full professor since 2015. From 2008 to 2016 he was full professor and chair at the Delft University of Technology, where he spearheaded the university's effort on cryogenic electronics for quantum computing as part of QuTech. He has been the driving force behind the creation of deep-submicron CMOS SPAD technology, which is mass-produced since 2015 and is present in smartphones, telemeters, proximity sensors, and medical diagnostics tools. His interests span from 3-D vision, LiDAR, FLIM, FCS, NIROT to super-resolution microscopy, time-resolved Raman spectroscopy, and cryo-CMOS circuits and systems for quantum computing. He has authored or co-authored over 400 papers and two books, and he holds 23 patents. Dr. Charbon is a distinguished visiting scholar of the W. M. Keck Institute for Space at Caltech, a fellow of the Kavli Institute of Nanoscience Delft, a distinguished lecturer of the IEEE Photonics Society, and a fellow of the IEEE.
Loïc Jean Pierre HerviouTeaching & PhD Courses Solid state physics III PHYS-419 The aim of this course is to provide an introduction to the theory of a few remarkable phenomena of modern condensed matter physics ranging from the quantum Hall effects to superconductivity.
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Didier TronoAfter obtaining an M.D. from the University of Geneva and completing a clinical training in pathology, internal medicine and infectious diseases in Geneva and at Massachusetts General Hospital in Boston, Didier Trono embarked in a scientific career at the Whitehead Institute for Biomedical Research of MIT. In 1990, he joined the faculty of the Salk Institute for Biological Studies to launch a center for AIDS research. He moved back to Europe seven years later, before taking the reins of the newly created EPFL School of Life Sciences, which he directed from 2004 to 2012. He is now actively engaged in the efforts of Switzerland to integrate new technologies in the fields of precision medicine and personalized health.
Robert DalangRobert Dalang, né en 1961, a reçu le diplôme de Mathématicien-EPFL en 1983 et est lauréat du Prix Dommer. Il passe l'année 1985-86 à Cornell University (USA) comme chercheur invité. Il obtient le doctorat au Département de mathématiques de l'EPFL en 1987. Son domaine de spécialisation est la théorie des processeurs stochastiques. En 1987, Robert Dalang est nommé professeur assistant au Département de statistiques de l'Université de Californie à Berkeley (USA). En 1988, il reçoit une bourse post-doctorale du Fonds national scientifique américain et effectue des recherches sur les propriétés markoviennes de processus stochastiques à plusieurs paramètres. En 1990, il est nommé à Tufts University (Boston, USA). Il est promu professeur associé en mai 1993. Une partie importante de ses recherches se font dans le cadre de contrats avec le Fonds national scientifique américain et l'Office de la recherche de l'armée américaine. En collaboration avec le Prof. R. Cairoli du Département de mathématiques de l'EPFL, il a écrit un livre sur l'optimisation stochastique séquentielle publié en 1996 aux éditions John Wiley. M. Dalang est nommé professeur extraordinaire de probabilités au Département de mathématiques en 1995. Il y poursuit des travaux de recherche en processus stochastiques et probabilité appliquée et participe à l'enseignement des processus stochastiques, de la théorie des probabilités et des cours de mathématiques aux sections d'ingénieurs. Il dirige régulièrement des thèses de doctorats, est éditeur de plusieurs journaux de recherche mathématique et travail en collaboration avec des chercheurs de plusieurs universités européennes et américaines.
Jevita PotheegadooAs a clinical neuropsychologist, I appreciate working with clinical populations, as I constantly learn a lot from the patients, enriching my knowledge not only on the illness but also on clinical and research practice.
I graduated from the University of Strasbourg (France), and obtained a Master's degree in clinical neuropsychology in 2005 from the University of Caen Basse-Normandie (France). I integrated the Psychiatry Department of the University Hospitals of Strasbourg as a neuropsychologist and pursued both clinical and research work on schizophrenia (INSERM unit). I investigated autobiographical memory impairment and self disorders in patients with schizophrenia, and obtained a Ph.D. in neuroscience (University of Strasbourg) in 2014. I joined the Blanke Lab (LNCO) as scientific collaborator in 2016.
Fosco Bernasconi2014-Present:
post-doc at the EPFL, Laboratory of Congitive Neuroscience.
2012-2014:
Postdoctoral Research Associate, Charité University Medicine, Berlin, Germany.
2012:
Postdoctoral Research Associate,Psychiatric University Hospital (PUK), Zurich, Switzerland.
2008-2011:
PhD in Neurosciences,Lemanic Neurosciences Doctoral School, Faculty of Biology and Medicine, Lausanne University, Switzerland.
2007-2008:
Master in Medical Biology,Faculty of Biology & Medicine, Lausanne University,Switzerland.
Eduardo Martin MoraudExpertise
The Moraud group develops closed-loop neuromodulation therapies for movement disorders, particularly Parkinson’s disease, with a specific emphasis on gait and balance impairments. The group integrates multimodal monitoring of motor and neural biomarkers to enable real-time decoding of dysfunctional states and their underlying neural dynamics, advancing a circuit-level understanding of locomotor control and informing the design of state-dependent adaptive therapies.
Mission
The group aims to transl
Mykhailo BatiukExpertise
Single cell and spatial genomics (wet/dry lab), glia, psychiatry, neuroscience
I obtained my PhD (2012-2018) in KU Leuven/VIB, Belgium where I investigated astrocyte heterogeneity using single cell transcriptomics. During this period I developed tools to acutely and specifically isolate astrocytes from adult brain and identified five astrocyte subtypes in the cortex and hippocampus of mouse brain expanding previous understanding of astrocyte variability.Following my PhD, I did my first post-doc in
